Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets - PubMed (original) (raw)

Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets

A Lanzavecchia et al. J Exp Med. 1988.

Abstract

We found that three tumor patients treated with mouse mAbs have T cells that recognize processed mouse Ig on autologous APC in a class II-restricted fashion, and we have shown that mouse mAbs directed against various cell surface molecules can be used as antigens to focus these T cells on an MHC class II-positive target of choice.

PubMed Disclaimer

Similar articles

• Function of the CD4 and CD8 molecules on human cytotoxic T lymphocytes: regulation of T cell triggering.
  Fleischer B, Schrezenmeier H, Wagner H. Fleischer B, et al. J Immunol. 1986 Mar 1;136(5):1625-8. J Immunol. 1986. PMID: 2419409
• Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
  Schirrmacher V, Schild HJ, Gückel B, von Hoegen P. Schirrmacher V, et al. Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36. Immunol Cell Biol. 1993. PMID: 7901150
• Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens.
  Flomenberg N, Naito K, Duffy E, Knowles RW, Evans RL, Dupont B. Flomenberg N, et al. Eur J Immunol. 1983 Nov;13(11):905-11. doi: 10.1002/eji.1830131109. Eur J Immunol. 1983. PMID: 6196208
• Antigen presentation: structural themes and functional variations.
  Braciale TJ, Braciale VL. Braciale TJ, et al. Immunol Today. 1991 Apr;12(4):124-9. doi: 10.1016/0167-5699(91)90096-C. Immunol Today. 1991. PMID: 1711855 Review.
• Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
  Reimann J, Böhm W, Schirmbeck R. Reimann J, et al. Biol Chem Hoppe Seyler. 1994 Nov;375(11):731-6. doi: 10.1515/bchm3.1994.375.11.731. Biol Chem Hoppe Seyler. 1994. PMID: 7535058 Review.

Cited by

• Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites.
  Ott MG, Marmé F, Moldenhauer G, Lindhofer H, Hennig M, Spannagl R, Essing MM, Linke R, Seimetz D. Ott MG, et al. Int J Cancer. 2012 May 1;130(9):2195-203. doi: 10.1002/ijc.26258. Epub 2011 Sep 27. Int J Cancer. 2012. PMID: 21702044 Free PMC article. Clinical Trial.
• Monoclonal antibodies in cancer therapy.
  Gruber R, Holz E, Riethmüller G. Gruber R, et al. Springer Semin Immunopathol. 1996;18(2):243-51. doi: 10.1007/BF00820669. Springer Semin Immunopathol. 1996. PMID: 8908703 Review. No abstract available.
• Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
  Buchegger F, Mach JP, Press OW, Bischof Delaloye A, Larson SM, Prior JO, Ketterer N. Buchegger F, et al. Ann Oncol. 2013 Jul;24(7):1948-1949. doi: 10.1093/annonc/mdt198. Epub 2013 May 23. Ann Oncol. 2013. PMID: 23704203 Free PMC article. No abstract available.
• Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor.
  Griffiths GM, Isaaz S. Griffiths GM, et al. J Cell Biol. 1993 Feb;120(4):885-96. doi: 10.1083/jcb.120.4.885. J Cell Biol. 1993. PMID: 8432729 Free PMC article.
• The Consequences of Multiple Simultaneous C-Type Lectin-Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN.
  García-Vallejo JJ, Bloem K, Knippels LM, Garssen J, van Vliet SJ, van Kooyk Y. García-Vallejo JJ, et al. Front Immunol. 2015 Mar 10;6:87. doi: 10.3389/fimmu.2015.00087. eCollection 2015. Front Immunol. 2015. PMID: 25806031 Free PMC article.

References

1. 1. J Exp Med. 1986 Jun 1;163(6):1539-52 - PubMed
2. 1. Nature. 1986 Feb 27-Mar 5;319(6056):778-80 - PubMed
3. 1. Blood. 1982 Jan;59(1):1-11 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851-5 - PubMed
5. 1. Scand J Immunol. 1976;5(6-7):745-57 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program